NuGen Medical Devices Inc (TSE:NGMD) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NuGen Medical Devices Inc. has announced a strategic partnership with EziAutoJector Limited to distribute its needle-free InsuJet devices for delivering U-100 insulin and other subcutaneous biosimilar products in the UK and Germany. This collaboration is expected to generate significant revenue and enhance the distribution of NuGen’s innovative drug-device combination products. The partnership aims to address the unmet need for needle-free drug delivery and expand NuGen’s market presence in managing conditions like diabetes and weight loss.
For further insights into TSE:NGMD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money